Lifeline Behavioral Health is a licensed substance use treatment provider in Tempe, AZ, listed in the SAMHSA treatment directory. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
IHS/Tribal/Urban (ITU) fundsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Children/AdolescentsYoung AdultsSeniors
Accreditation
State mental health departmentState department of healthCouncil on Accreditation (COA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentFederal, or any government funding for substance use treatment programsMedicaid
2525 South Rural Road, Suites 9 and 10-N, Tempe, AZ 85282
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare